Feasibility study of a short Bevacizumab infusion in patients.
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
Interventions: Bevacizumab is administered in 0.5mg/kg/min. Primary outcome(s): Having onset of hypersensitivity reaction or not Study Design: Single arm Non-randomized
创建时间：
2015-06-15
